VIE - Viela Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.44B
Enterprise Value 3
1.71B
Trailing P/E
N/A
Forward P/E 1
-9.30
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
71.81
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
85.64
Enterprise Value/EBITDA 6
-18.55

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 318.16%
52 Week High 333.70
52 Week Low 318.20
50-Day Moving Average 325.96
200-Day Moving Average 324.50

Share Statistics

Avg Vol (3 month) 3160.46k
Avg Vol (10 day) 3123.98k
Shares Outstanding 550.96M
Float 14.08M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Nov 15, 2019) 4704.02k
Short Ratio (Nov 15, 2019) 410.11
Short % of Float (Nov 15, 2019) 43.46%
Short % of Shares Outstanding (Nov 15, 2019) 41.38%
Shares Short (prior month Oct 15, 2019) 4440.08k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-461.88%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)20M
Revenue Per Share (ttm)22.93
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -92.35M
Net Income Avi to Common (ttm)-89.91M
Diluted EPS (ttm)-103.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)198.24M
Total Cash Per Share (mrq)3.89
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.92
Book Value Per Share (mrq)-297.67

Cash Flow Statement

Operating Cash Flow (ttm)-83.14M
Levered Free Cash Flow (ttm)N/A